Identifying chronic thromboembolic pulmonary hypertension (CTEPH) through French national hospital database (PMSI) Source: International Congress 2018 – Clinical aspects of pulmonary hypertension Year: 2018
Incidence and prevalence of IPF in an insurance claims database: Assessing accuracy using medical records Source: International Congress 2014 – Respiratory disease within hospital-based populations Year: 2014
Chronic pulmonary aspergillosis in France: prevalence, associated chronic pulmonary diseases and prognosis in a 10-year retrospective study of the French nationwide administrative hospital database. Source: International Congress 2019 – Clinical challenges in respiratory infection Year: 2019
Asthma and chronic obstructive pulmonary disease training in an online environment: a new response to a growing problem Source: International Congress 2019 – Nursing care across the spectrum of respiratory illnesses Year: 2019
Information on coexisting diseases in patient files in newly referred COPD patients in the KOLibri study Source: Annual Congress 2007 - Impact of comorbidities in pulmonary rehabilitation Year: 2007
Epidemiology and mortality of non-idiopathic pulmonary fibrosis (IPF) progressive fibrosing interstitial lung disease (PF-ILD) using the French national health insurance system (SNDS) database in France: the PROGRESS study Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more Year: 2020
Pulmonary aspergillosis: a clinical review Source: Eur Respir Rev 2011; 20: 156-174 Year: 2011
Severe pulmonary sarcoidosis: definition and risk stratification Source: Virtual Congress 2020 – Severe thoracic sarcoidosis : where do we stand ? Year: 2020
Which algorithm diagnoses invasive pulmonary aspergillosis best in ICU patients with COPD? Source: Eur Respir J, 50 (3) 1700532; 10.1183/13993003.00532-2017 Year: 2017
Differentiating asthma from chronic obstructive pulmonary disease (COPD) in medico-economic databases: myth or reality? Source: International Congress 2019 – Tuberculosis epidemiology, bronchiectasis, other infections and spirometry Year: 2019
TOPP: the first international registry in pediatric pulmonary hypertension Source: Annual Congress 2008 - Pulmonary hypertension I Year: 2008
Optimizing chronic obstructive pulmonary disease (COPD) diagnosis and management to reduce healthcare costs: Systematic review and modeling Source: Annual Congress 2013 –Health economics of airway diseases Year: 2013
Severe asthma: one disease many definitions Source: International Congress 2019 – Asthma and the world Year: 2019
Impact of underlying respiratory diseases on clinical features and prognosis of chronic pulmonary aspergillosis Source: International Congress 2015 – Immunodepression and severe pneumonia Year: 2015
Specifying pediatric pulmonary hemorrhage: Suggestion of a diagnostic algorithm as guide to disease subcategories Source: Virtual Congress 2021 – Exploring the phenotypic heterogeneity across rare diffuse parenchymal lung diseases Year: 2021
Chronic pulmonary aspergillosis: prevalence, favouring pulmonary diseases and prognosis Source: Eur Respir J, 58 (2) 2003345; 10.1183/13993003.03345-2020 Year: 2021
Rising COVID-19 related acute pulmonary emboli but falling national chronic thromboembolic pulmonary hypertension referrals from a large national dataset Source: ERJ Open Res, 7 (4) 00431-2021; 10.1183/23120541.00431-2021 Year: 2021
Exacerbations, hospitalisations and mortality in patients with idiopathic pulmonary fibrosis in clinical practice: INSIGHTS-IPF registry Source: International Congress 2017 – Idiopathic pulmonary fibrosis (IPF): clinical problems Year: 2017
Evaluation of the incidence of rare diseases: difficulties and uncertainties, the example of chronic thromboembolic pulmonary hypertension Source: Eur Respir J , 49 (2) 1602522; DOI: 10.1183/13993003.02522-2016 Year: 2017
A global registry for idiopathic pulmonary fibrosis: the time is now Source: Eur Respir J 2014; 44: 273-276 Year: 2014